[177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial
Article in The Lancet Oncology (April 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in The Lancet Oncology (April 2024)
Book chapter (June 2023)
Article in The Medical Journal of Australia (September 2022)